by John McMillan | Aug 23, 2024 | COVID-19, Immune Response, Inflammation, STORM
Dr. Philip McMillan, John McMillan The concept of a COVID-19 “STORM” (Spike-Triggered Autoimmune Response Mechanism) is emerging as a potential concern in the ongoing pandemic. This theory, proposed by Dr. Philip McMillan, suggests that circulating...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Nasia Safdar, University of Wisconsin-Madison A new study from the National Institutes of Health shows a jump in both hospital-acquired infections and resistance to the antibiotics used to treat them. The findings are based on data gathered at 120 U.S. hospitals from...
by John McMillan | Aug 16, 2024 | COVID-19, Medical Research
Ziyad Al-Aly, Washington University in St. Louis Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
by John McMillan | Aug 16, 2024 | Health, Virology
C Raina MacIntyre, UNSW Sydney The World Health Organization (WHO) has declared mpox a public health emergency of international concern, after rising cases in the Democratic Republic of the Congo and the potential for further spread. This now triggers a coordinated...
Recent Comments